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Background and aims: High glucose-induced damage in microvascular cells in vitro and progression of 
retinopathy and nephropathy in diabetic animals are prevented by thiamine supplementation. Impaired 
thiamine availability facilitates metabolic damage, and renal loss of this vitamin is described in diabetic 
patients. Two SNPs located in the SLC19A3 gene encoding for the thiamine transporter-2 (ThTR-2) are 
associated with resistance to development of proliferative diabetic retinopathy and end-stage renal disease 
in type 1 diabetic subjects, but the mechanisms of these protective effects remain to be understood. We 
previously showed that diabetic-like conditions modulate ThTR-2 expression in human retinal cells. Our 
aim was to further investigate the involvement of the two thiamine transporters ThTR-1 and ThTR-2 and 
their transcription factor Sp1 in high glucose-induced damage and altered thiamine metabolism in cell 
models mimicking the diabetic retinopathy microenvironment. 
Materials and methods: Human retinal pericytes (HRP), human microvascular endothelial cells 
(HMEC) and human Müller cells (MIO-M1) were cultured for 8 days in physiological glucose (NG), 
stable high glucose (HG) or intermittent high glucose (intHG). Cells were also cultivated in thiamine-
deficient medium (noT) or high thiamine conditions (HT), to evaluate substrate influence. Transketolase 
(TK) activity and intracellular thiamine concentration were studied through metabolic assays, and cellular 
localization of the transporters by immunofluorescence staining (IF). To better mimic the retinal 
microenvironment and the complex intercellular exchanges, triple co-cultures were established. ThTR-1, 
ThTR-2 and Sp1 mRNA and protein expression were checked by RT-PCR and Western blotting. 
Results: TK activity and intracellular thiamine were markedly decreased in HRP and HMEC cultured in 
noT, as expected, and increased in HRP cultured in HT. Increased intracellular thiamine and TK activity 
were found in MIO-M1 cultured in HG and intHG and, surprisingly, in HG and intHG without thiamine. 
IF staining evidenced cytoplasmic localization of ThTR-1 and Sp1 in all cell types. ThTR-2 showed a 
characteristic nuclear speckle distribution in HRP and MIO-M1, while in HMEC it was uniformly 
distributed in the cytoplasm. As regards co-culture models, ThTR-1 and Sp1 expression were unchanged 
in all cell types regardless of treatment, whereas ThTR-2 mRNA and protein expression were decreased 
in HRP, HMEC and MIO-M1 cultured in HG and intHG conditions, showing differences from data in 
single cultures. 
Conclusion: Down-regulation of ThTR-2 in co-culture models mimicking the diabetic retinal 
microenvironment suggests its major role in thiamine transport in retinal cells and its involvement in high 
glucose-induced damage and impaired thiamine metabolism. As expected, altered thiamine 
supplementation influences TK activity. The increased intracellular thiamine and TK activity in Müller 
cells following deficient thiamine supplementation may be interpreted as an adaptive mechanism of these 
cells to counteract lack of substrate. 
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